By: Springer S.B. No. 403
 
 
 
   
 
 
A BILL TO BE ENTITLED
 
AN ACT
         relating to a study on the side effects, adverse reactions,
  including death, and the effectiveness of vaccines against the
  SARS-CoV-2 virus (COVID-19) or its variants.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
  SECTION 1.  (a) In this section:
         1) "Commission" means the Health and Human Services
  Commission.
         2) "Executive commissioner" means the executive commissioner
  of the Health and Human Services Commission.
         3) "Department" means the Department of State Health
  Services.
         4) "COVID-19" means the SARS-CoV-2 virus and any of its
  variants.
         5) "Vaccine" means a substance used to stimulate immunity to
  a particular infectious disease or pathogen, typically prepared
  from an inactivated or weakened form of the causative agent or from
  its constituents or products.
  (b)  The Commission in collaboration with the Department shall
  conduct a study to assess the full and complete adverse reactions,
  including death, and effectiveness of each type of vaccine used in
  Texas to defend the human body against "COVID-19. The Report must
  include:
         1) The immediate short-term side effects and adverse
  reactions recipients experienced from taking the various COVID-19
  vaccines used in Texas; including but not limited to include:
               i.  Pain, swelling, or redness where the shot was given
               ii.  Mild fever
               iii.  Chills
               iv.  Feeling tired
               v.  Headache
               vi.  Muscle and joint aches
         2) The immediate serious side effects and adverse reactions
  recipients experienced from taking the various COVID-19 vaccines
  used in Texas; including but not limited to include:
               i.  difficulty breathing;
               ii.  swelling of the face and throat;
               iii.  accelerated heartbeat;
               iv.  a body rash;
               v.  dizziness; and
               vi.  weakness
         3) Any long-term side effects and adverse reactions
  recipients have experienced from taking the various COVID-19
  vaccines used in Texas; including but not limited to include:
               i.  paralysis;
               ii.  Myocarditis;
               iii.  clotting disorders;
               iv.  Thrombosis with Thrombocytopenia Syndrome (TTS);
               v.  Guillain-Barré syndrome (GBS);
               vi.  difficulty thinking or "brain fog,"
               vii.  chronic pain;
               viii.  tiredness and fatigue;
               ix.  loss of taste;
               x.  depression;
               xi.  anxiety; and
               xii.  death.
               4) Any misrepresentations about the effectiveness or
  dangers of taking of the vaccine by its manufacturers or any
  governmental agency; and,
               5) Any concealment of information about the
  effectiveness or dangers of taking of the vaccine by its
  manufacturers or any governmental agency.
  (c) The Commission and the Department shall gather information for
  the report from:
         1) information collected by the Commission and the
  Department, including information from the department's vital
  statistics unit and the state Medicaid program;
         2) hospitals, treatment centers, available surveys; and
         3) and other relevant sources.
  SECTION 2.  (a) Not later than January 1, 2024, the Commission and
  Department shall prepare and submit to the Governor, Lieutenant
  Governor, the Speaker of the House of Representatives, and the
  Chairpersons of the relevant Texas legislative committees with
  jurisdiction over the Commission and the Department, a copy of the
  report, summary of any findings, and any recommendations for
  legislative or executive action to reduce the prevalence of
  COVID-19 Vaccine side effects. The department may post the report
  on the department's Internet website.
  (b)  The Commission and Department may accept gifts, grants,
  and donations from any source to fund expenses
  incurred by the Commission and the Department in
  preparing the report.
  SECTION 3.  This Act expires September 1, 2025.
  SECTION 4.  This Act takes effect immediately if it receives a vote
  of two-thirds of all the members elected to each house, as provided
  by Section 39, Article III, Texas Constitution. If this Act does
  not receive the vote necessary for immediate effect, this Act takes
  effect September 1, 2023.